San Diego-based Viking Therapeutics marked alone as a serious competitor from the weight loss drug current market in February right after revealing promising data from the mid-stage trial of experimental drug VK2735, which instructed it rivaled—and outperformed—Novo and Lilly drugs when offered as a weekly injection As well as in March the comp